M&A Deal Summary

Thermo Fisher Scientific Acquires Solventu - Purification & Filtration Business

On February 25, 2025, Thermo Fisher Scientific acquired test/measurement equipment company Solventu - Purification & Filtration Business from Solventum for 4.1B USD

Acquisition Highlights
  • This is Thermo Fisher Scientific’s 12th transaction in the Test/Measurement Equipment sector.
  • This is Thermo Fisher Scientific’s 7th largest (disclosed) transaction.
  • This is Thermo Fisher Scientific’s 39th transaction in the United States.
  • This is Thermo Fisher Scientific’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2025-02-25
Target Solventu - Purification & Filtration Business
Sector Test/Measurement Equipment
Buyer(s) Thermo Fisher Scientific
Sellers(s) Solventum
Deal Type Divestiture
Deal Value 4.1B USD

Target

Solventu - Purification & Filtration Business

Saint Paul, Minnesota, United States
Solventu's Purification & Filtration Business is a provider of Purification & Filtration sevices in healthcare Industry.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Thermo Fisher Scientific

Waltham, Massachusetts, United States

Category Company
Founded 1956
Sector Test/Measurement Equipment
Employees122,000
Revenue 42.9B USD (2024)
DESCRIPTION
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.
Thermo Fisher's corporate headquarters in Waltham, Massachusetts.

Thermo Scientific provides analytical instruments, laboratory equipment, software, services, consumables and reagents for better workflow solutions spanning sample preparation, sample analysis, and data interpretation. Thermo Fisher Scientific was founded in 1956 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 63 of 65
Sector: Test/Measurement Equipment M&A 12 of 12
Type: Divestiture M&A Deals 7 of 8
State: Minnesota M&A 1 of 1
Country: United States M&A 39 of 41
Year: 2025 M&A 1 of 3
Size (of disclosed) 7 of 29
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-17 Olink

Uppsala, Sweden

Olink provides leading solutions for advanced proteomics research and development, enabling biopharmaceutical companies and leading academic researchers to quickly and efficiently understand diseases at the protein level. Olink's proprietary technology, Proximity Extension Assay (PEA), enables high-throughput protein analysis for the very large installed base of qPCR and next-generation sequencing readout systems on the market. Olink was founded in 2016 and is based in Uppsala, Sweden.

Buy $3.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-02 Sanofi - Sterile Fill-Finish & Packaging Site

Ridgefield, New Jersey, United States

Sanofi - Sterile Fill-Finish & Packaging Site is a sterile fill-finish manufacturing site.

Buy -

Seller(S) 1

SELLER

Solventum

Saint Paul, Minnesota, United States

Category Company
Founded 2023
Sector Diversified
Employees22,000
Revenue 8.3B USD (2024)
DESCRIPTION

Solventum is a healthcare solutions span across four business segments – medical surgical, dental solutions, health information systems and purification and filtration. Solventum was founded in 2023 and is based in Saint Paul, Minnesota.


DEAL STATS #
Overall 1 of 1
Sector: Test/Measurement Equipment M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Minnesota M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-11-20 Acera Surgical

St. Louis, Missouri, United States

Acera Surgical is a bioscience company that develops and commercialises engineered synthetic materials for soft-tissue repair and regenerative wound care. Acera Surgical was founded in 2013 and is based in St. Louis, Missouri.

Buy $725M